Pàgina inicial > Articles > Articles publicats > Resultats de la cerca: 2234-943X_a2020v10n

Articles publicats

  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Articles publicats 3 registres trobats  La cerca s'ha fet en 0.03 segons. 
1.
15 p, 1.5 MB Sirtuin 1 Inhibiting Thiocyanates (S1th)-A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine Deacetylases / Wössner, Nathalie (Institute of Pharmaceutical Sciences. University of Freiburg. Department of Pharmaceutical and Medicinal Chemistry) ; Alhalabi, Zayan (Institute of Pharmacy. University of Halle-Wittenberg. Department of Medicinal Chemistry) ; González Miranda, Jessica (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Swyter, Sören (Institute of Pharmaceutical Sciences. University of Freiburg) ; Gan, Jin (Oncode Institute, Leiden University Medical Center, Leiden) ; Schmidtkunz, Karin (Department of Pharmaceutical and Medicinal Chemistry. Institute of Pharmaceutical Sciences. University of Freiburg) ; Zhang, Lin (Department of Protein Crystallography. Institute of Biochemistry. University of Freiburg) ; Vaquero, Alejandro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ovaa, Huib (Oncode Institute. Leiden University Medical Center) ; Einsle, Oliver (Department of Protein Crystallography. Institute of Biochemistry. University of Freiburg) ; Sippl, Wolfgang (Department of Medicinal Chemistry. Institute of Pharmacy. University of Halle-Wittenberg) ; Jung, Manfred (Department of Pharmaceutical and Medicinal Chemistry. Institute of Pharmaceutical Sciences. University of Freiburg) ; Universitat Autònoma de Barcelona
Sirtuin 1 (Sirt1) is a NAD dependent lysine deacetylase associated with the pathogenesis of various diseases including cancer. In many cancer types Sirt1 expression is increased and higher levels have been associated with metastasis and poor prognosis. [...]
2020 - 10.3389/fonc.2020.00657
Frontiers in Oncology, Vol. 10 (30 2020) , p. 657  
Registre complet - Creative Commons
2.
0 p, 170.6 KB Commentary : SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China / Di Cosimo, Serena (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) ; Porcu, Luca (Istituto di Ricerche Farmacologiche Mario Negri IRCCS) ; Malfettone, Andrea (Medica Scientia Innovation Research (New Jersey, Estats Units d'Amèrica)) ; Cortés, Javier (Vall d'Hebron Institut d'Oncologia) ; Miceli, Rosalba (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano. Department of Applied Research and Technological Development) ; Universitat Autònoma de Barcelona
2020 - 10.3389/fonc.2020.01223
Frontiers in Oncology, Vol. 10 (july 2020) , p. 1223  
Registre complet - Creative Commons
3.
14 p, 1.4 MB Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors / Pasculli, Barbara (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratorio di Oncologia) ; Barbano, Raffaela (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratorio di Oncologia) ; Fontana, Andrea (Fondazione IRCCS Casa Sollievo Della Sofferenza) ; Biagini, T. (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratory of Bioinformatics Unit) ; Di Viesti, M. P. (Department of Medicine. Scuola Medica Salernitana," University of Salerno) ; Rendina, M. (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratorio di Oncologia) ; Valori, V. M. (Fondazione IRCCS Casa Sollievo Della Sofferenza. UO di Oncologia. San Giovanni Rotondo) ; Morritti, M. (Fondazione IRCCS Casa Sollievo Della Sofferenza. UO di Oncologia. San Giovanni Rotondo) ; Bravaccini, Sara (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS. Biosciences Laboratory) ; Ravaioli, S. (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS. Biosciences Laboratory) ; Maiello, Evaristo (Fondazione IRCCS Casa Sollievo Della Sofferenza. UO di Oncologia. San Giovanni Rotondo) ; Graziano, Paolo (Fondazione IRCCS Casa Sollievo Della Sofferenza) ; Murgo, R. (Fondazione IRCCS Casa Sollievo Della Sofferenza) ; Copetti, Massimiliano (Fondazione IRCCS Casa Sollievo Della Sofferenza) ; Mazza, T. (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratory of Bioinformatics Unit) ; Fazio, V. M. (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratorio di Oncologia) ; Esteller, M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Parrella, Paola (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratorio di Oncologia) ; Universitat Autònoma de Barcelona
miR-155-5p is a well-known oncogenic microRNA, showing frequent overexpression in human malignancies, including breast cancer. Here, we show that high miR-155-5p levels are associated with unfavorable prognostic factors in two independent breast cancer cohorts (CSS cohort, n = 283; and TCGA-BRCA dataset, n = 1,095). [...]
2020 - 10.3389/fonc.2020.01415
Frontiers in Oncology, Vol. 10 (december 2020) , p. 1415  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem